[Federal Register Volume 86, Number 171 (Wednesday, September 8, 2021)]
[Notices]
[Pages 50362-50363]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19444]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-3263]


Request for Nominations for Voting Members on a Public Advisory 
Committee; the Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Tobacco Products Scientific 
Advisory Committee, in the Center for Tobacco Products. FDA seeks to 
include the views of women and men, members of all racial and ethnic 
groups, and individuals with and without disabilities on its advisory 
committees and, therefore encourages nominations of appropriately 
qualified candidates from these groups.

DATES: Nominations received on or before November 8, 2021 will be given 
first consideration for membership on the Tobacco Products Scientific 
Advisory Committee. Nominations received after November 8, 2021 will be 
considered for nomination to the committee as later vacancies occur.

ADDRESSES: All nominations for membership should be sent electronically 
by logging into the FDA Advisory Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm. 
Information about becoming a member on an FDA advisory committee can 
also be obtained by visiting FDA's website by using the following link: 
https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is: Serina Hunter-Thomas, Office of 
Science, Center for Tobacco Products, Food and Drug Administration, 
Center for Tobacco Products, Document Control Center, Bldg. 71, Rm. 
G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-
287-1373 (choose Option 5), email: <a href="/cdn-cgi/l/email-protection#7f2b2f2c3e3c3f191b1e5117170c51181009"><span class="__cf_email__" data-cfemail="df8b8f8c9e9c9fb9bbbef1b7b7acf1b8b0a9">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting 
members on the Tobacco Products Scientific Advisory Committee.

[[Page 50363]]

I. General Description of the Committee Duties

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of FDA (the Commissioner) or designee in 
discharging responsibilities related to the regulation of tobacco 
products. The Committee reviews and evaluates behavior, dependence, and 
health issues, among others, relating to tobacco products and provides 
appropriate advice, information, and recommendations to the 
Commissioner.

II. Criteria for Voting Members

    The Committee shall consist of 12 members, including the Chair. 
Members and the Chair are selected by the Commissioner or designee from 
among individuals knowledgeable in the fields of science, medicine, 
medical ethics, or technology involving the manufacture, evaluation, or 
use of tobacco products. Almost all non-Federal members of this 
committee serve as Special Government Employees. The Committee shall 
include nine technically qualified voting members, selected by the 
Commissioner or designee. The nine voting members shall be scientists, 
physicians, dentists, or healthcare professionals practicing in the 
areas of oncology, pulmonology, cardiology, toxicology, pharmacology, 
addiction, epidemiology, behavioral health, or any other relevant 
specialty. One member shall be an officer or employee of a state or 
local government or of the Federal Government. The final voting member 
shall be a representative of the general public. Members will be 
invited to serve for terms of up to 4 years.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete 
r[eacute]sum[eacute] or curriculum vitae for each nominee, including 
current business address and/or home address, telephone number, and 
email address if available and a signed copy of the Acknowledgement and 
Consent form available at the FDA Advisory Nomination Portal (see 
ADDRESSES). Nominations must also specify the advisory committee for 
which the nominee is recommended. Nominations must also acknowledge 
that the nominee is aware of the nomination unless self-nominated. FDA 
will ask potential candidates to provide detailed information 
concerning such matters related to financial holdings, employment, and 
research grants and/or contracts to permit evaluation of possible 
sources of conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 2, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-19444 Filed 9-7-21; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>